Disclosures for "Severe Necrotizing Myositis in a Patient with Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR), Melanoma Differentiation-Associated Gene 5 (MDA-5), Clinically Amyopathic Dermatomyositis 140 (CADM-140), Nuclear Matrix Protein 2 (NXP-2), and Ribonucleoprotein (RNP) antibodies without Dermatologic Involvement "